Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
November 2006
Features
Persistence with Pharmacotherapy for Gastrointestinal Disease: Associated Costs of Health Care
A study was conducted to assess the association between health care costs and patient adherence to aminosalicylate pharmacotherapy for digestive disorders.
Fadia T. Shaya, PhD, MPH, Antoine C. El Khoury, PhD, Winston Wong, PharmD, Nevin Whitelaw, BSc, George Whitelaw, RPh, Raymond E. Joseph, MD, and Russell D. Cohen, MD
Consensus Statement on the Use of Botulinum Neurotoxin to Treat Spasticity in Adults
The Neurotoxin Spasticity Consensus Group presents its findings on botulinum toxin in the treatment of various conditions characterized by muscle overactivity.
Thomas L. Davis, MD, Matthew A. Brodsky, MD, Victoria A. Carter, MD, Marc DiFazio, MD, Ben Frishberg, MD, Eugene C. Lai, MD, PhD, John McGuire, MD, Douglas P. Meyer, RPh, Jill L. Ostrem, MD, Aliya I. Sarwar, MD, and Kevin White, MD
Meeting Highlights
World Congress of Cardiology 2006
The safety and efficacy of ACE-inhibitors (ramipril, perindopril, and trandolapril), an angiotensin-receptor blocker (valsartan), an anticoagulant/antiplatelet combination, and a direct renin inhibitor (aliskiren) are reviewed.
Reuben B. David
Meeting Highlights
46th Interscience Conference on Antimicrobial Agents and Chemotherapy
The authors report on ceftaroline for skin and skin-structure infections; cethromycin for acute bacterial exacerbations of chronic bronchitis; tigecycline for community-acquired pneumonia; ceftobiprole for skin infections; moxifloxacin for leprosy; telithromycin for acute bacterial sinusitis; oseltamivir to reduce pneumonia risk following pediatric influenza; a human papillomavirus vaccine; and micafungin for invasive candidiasis in children.
Lawrence M. Prescott, PhD, and Sharon L. Prescott
Pharmaceutical Approval Update
Three agents are discussed: posaconazole oral suspension (Noxafil) for Aspergillus and Candida infections; Travoprost Z ophthalmic solution (Travatan Z), for glaucoma or ocular hypertension; and arformoterol tartrate inhalation solution (Brovana) for obstructive pulmonary disease, chronic bronchitis, and emphysema.
Marvin M. Goldenberg, PhD, RPh, MS
Departments
Editorial
Ready for Registries?
David Nash, MD, MBA, discusses the advantages of electronic medical records and the forthcoming development of linked registries that hold promise for improving outcomes for patients with chronic disease.
David Nash, MD, MBA
Medication Errors
ISMP Survey Results: Pharmacy Interventions Can Reduce Clinical Errors
Matthew Grissinger, RPh, FASCP, reports on the results of a survey about the role of appropriate interventions for preventing clinical errors.
Matthew Grissinger, RPh, FASCP
Prescription: Washington
A First Step Toward Measuring Pharmacy Performance: Will the Pharmacy Quality Alliance Lead the Way?
Stephen Barlas discusses the Pharmacy Quality Alliance, a collaboration to develop new strategies for measuring pharmacy performance, with the goal of improving patient outcomes.
Stephen Barlas
New Drugs/Drug News/New Medical Devices
P&T presents the latest studies and information about FDA approvals, drug indications, industry updates, and new devices.
Drug Forecast
Anidulafungin (Eraxis) for Fungal Infections
The authors review anidulafungin (Eraxis) for the treatment of fungal infections.
Priti N. Patel, PharmD, BCPS, and Lisa Charneski, PharmD, BCPS
